Skip to main content

Table 3 Protocol design for the administration of methylphenidate that followed AABAA single case methodology

From: Methylphenidate improves executive functions in patients with traumatic brain injuries: a feasibility trial via the idiographic approach

A

Baseline 1 (BL1)

*A

Baseline 2 (BL2)

**B

Maximum dose of methylphenidate (MAXMETH)

***A

Post-withdrawal 1 (POST1)

***A

Post-withdrawal 2 (POST2)

  1. * BL2 evaluations conducted over 15 days of BL1 and then the institution of drug treatment (the starting dose was 5 mg/day, increasing to a maximum dosage of 10 mg/day)
  2. ** MAXMETH evaluations conducted at 30 days after BL2
  3. *** Follow-up evaluations (POST1) were conducted at 15 days after the MAXMETH evaluation while POST2 was conducted after 15 days after POST1
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us